DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Scott Weiner will moderate a discussion on the current IPO market at BIO International Convention 2013 in Chicago.
